NCT00510107View on ClinicalTrials.gov

Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC

PHASE2UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

July 31, 2009

Conditions
Stomach NeoplasmStage IVRecurrent
Interventions
DRUG

oxaliplatin

oxaliplatin 120 mg/m2 will be given on day 1.

DRUG

Cisplatin

Cisplatin 60 mg/m2 will be given on day 1.

Trial Locations (1)

405 760

RECRUITING

Gachon University Gil Medical Center, Incheon

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Gachon University Gil Medical Center

OTHER

NCT00510107 - Weekly Docetaxel Plus Cisplatin or Oxaliplatin for AGC | Biotech Hunter | Biotech Hunter